Dr. Dean Fergusson

Dr. Dean Fergusson is a member of the AOC and the Co-Chair of the ACT Systems Transformation Committee. He is the Director of the Clinical Epidemiology Program at the Ottawa Hospital Research Institute (OHRI). An international leader in transfusion medicine, his trials have advanced knowledge and practice on the optimal blood products to transfuse, establishing timelines to administer transfusions, and evaluating transfusion alternatives. His methodological work in the areas of pragmatic trials, clinical equipoise, post-randomization exclusions, ethical use of placebos, and statistical approaches has influenced the practice and reporting of clinical trials globally. He has received >$250M in peer-reviewed research grants. He is one of the most cited and impactful clinical trialists in Canada, having published >650 peer-reviewed articles, many in high-impact journals.

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.